Índice APRI

"Aspartate aminotransferase to platelet ratio index"

Es utilizado cuando hay Sospecha de Cirrosis, pero no esta confirmada

In a meta-analysis of 40 studies, investigators concluded that an APRI score greater than 1.0 had a sensitivity of 76% and specificity of 72% for predicting cirrhosis. In addition, they concluded that APRI score greater than 0.7 had a sensitivity of 77% and specificity of 72% for predicting significant hepatic fibrosis. For detection of cirrhosis, using an APRI cutoff score of 2.0 was more specific (91%) but less sensitive (46%).

The lower the APRI score (less than 0.5), the greater the negative predictive value (and ability to rule out cirrhosis) and the higher the value (greater than 1.5) the greater the positive predictive value (and ability to rule in cirrhosis); midrange values are less helpful. The APRI alone is likely not sufficiently sensitive to rule out significant disease. Some evidence suggests that the use of multiple indices in combination (such as APRI plus FibroTest) or an algorithmic approach may result in higher diagnostic accuracy than using APRI alone.

Descarga
Utilidad del índice Aspartato-aminotransferasa/ plaquetas (APRI) en el diagnóstico no invasivo de fi brosis hepática en niños y adolescentes obesos con enfermedad hepática grasa no alcohól
Utilidad del índice Aspartato-aminotran
Documento Adobe Acrobat 172.0 KB
Descarga
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
AST to platelet ratio index (APRI) for t
Documento Adobe Acrobat 127.3 KB